-
Completed
NCT NCT00871572
A Study for Participants With Type 2 Diabetes Mellitus
Not yet reported
Eli Lilly and Company
87 participants
Est. completion 2010-02
19 sites
Stand-alone
Type 2 diabetes
View official trial listing →
-
Completed
NCT NCT01241448
A Study of LY2409021 in Patients With Type 2 Diabetes
Not yet reported
Eli Lilly and Company
263 participants
Est. completion 2012-03
40 sites
Stand-alone
Type 2 diabetes
View official trial listing →
-
Completed
NCT NCT01354496
A Study of LY2409021 Formulations and the Effect of Food
Not yet reported
Eli Lilly and Company
35 participants
Est. completion 2011-10
1 site
Stand-alone
Other conditions: Healthy Volunteers
View official trial listing →
-
Completed
NCT NCT01460368
A Study on the Effects of LY2409021 on the Electrical Impulses of the Heart
Not yet reported
Eli Lilly and Company
67 participants
Est. completion 2012-03
1 site
Stand-alone
Type 2 diabetes
View official trial listing →
-
Completed
NCT NCT01588366
The Effects of LY2409021 on the Liver
Not yet reported
Eli Lilly and Company
30 participants
Est. completion 2013-09
1 site
Stand-alone
Type 2 diabetes
View official trial listing →
-
Completed
NCT NCT01606371
A First-in-Human Study of LY2409021 in Healthy Participants and Participants With Type 2 Diabetes
Not yet reported
Eli Lilly and Company
32 participants
Est. completion 2007-10
1 site
Stand-alone
Type 2 diabetes
View official trial listing →
-
Completed
NCT NCT01606397
A Study of Multiple Increasing Doses of LY2409021 in Participants With Type 2 Diabetes
Not yet reported
Eli Lilly and Company
50 participants
Est. completion 2008-11
2 sites
Stand-alone
Type 2 diabetes
View official trial listing →
-
Completed
NCT NCT01606423
The Effect of LY2409021 on Blood Sugar Levels When Glucagon Levels Are Increased in Healthy Male Participants
Not yet reported
Eli Lilly and Company
21 participants
Est. completion 2008-03
1 site
Stand-alone
Other conditions: Healthy Volunteers
View official trial listing →
-
Completed
NCT NCT01640834
Study of LY2409021 in Participants With Type 1 Diabetes
Not yet reported
Eli Lilly and Company
20 participants
Est. completion 2012-09
1 site
Stand-alone
Other conditions: Diabetes Mellitus, Type 1
View official trial listing →
-
Completed
NCT NCT01836198
The Effect of Gemfibrozil, Ketoconazole and Clarithromycin on the Amount of LY2409021 in the Bloodstream
Not yet reported
Eli Lilly and Company
30 participants
Est. completion 2013-11
1 site
Stand-alone
Other conditions: Healthy Volunteers
View official trial listing →
-
Completed
NCT NCT01929109
A Study of LY2409021 in Participants With Different Levels of Kidney Function
Not yet reported
Eli Lilly and Company
47 participants
Est. completion 2014-08
2 sites
Stand-alone
Other conditions: Kidney Failure, Chronic, Renal Insufficiency, Chronic
View official trial listing →
-
Completed
NCT NCT02091362
A Study of LY2409021 on Blood Pressure and Pulse Rate in Participants With Type 2 Diabetes Mellitus
Not yet reported
Eli Lilly and Company
270 participants
Est. completion 2015-01
30 sites
Stand-alone
Type 2 diabetes
View official trial listing →
-
Terminated
NCT NCT02111096
A Study of LY2409021 in Participants With Type 2 Diabetes Mellitus
Not yet reported
Eli Lilly and Company
174 participants
Est. completion 2015-09
33 sites
Stand-alone
Type 2 diabetes
View official trial listing →
-
Completed
NCT NCT02217618
A Study of LY2409021 in Healthy Participants
Not yet reported
Eli Lilly and Company
16 participants
Est. completion 2014-09
1 site
Stand-alone
Other conditions: Healthy Participants
View official trial listing →
-
Terminated
NCT NCT02385084
A Study of LY2409021 Formulations in Healthy Participants
Not yet reported
Eli Lilly and Company
18 participants
Est. completion 2015-05
1 site
Stand-alone
Other conditions: Healthy
View official trial listing →
-
Completed
NCT NCT02669524
Dissection of the Gastrointestinal-mediated Glucose Disposal and Incretin Defect in Patients With Type 2 Diabetes
Not yet reported
University Hospital, Gentofte, Copenhagen
20 participants
Est. completion 2016-08
1 site
Type 2 diabetes
View official trial listing →
-
Completed
NCT NCT02792400
The Role of Glucagon in the Effects of Dipeptidyl Peptidase-4 Inhibitors and Sodium-glucose Co-transporter-2 Inhibitors
Not yet reported
University Hospital, Gentofte, Copenhagen
24 participants
Est. completion 2018-07
1 site
Type 2 diabetes
View official trial listing →
-
Status unknown
NCT NCT02944110
Delineation of the Diabetogenic Role of Extrapancreatic Glucagon in Totally Pancreatectomised Patients Using Glucagon Receptor Antagonism
Not yet reported
University Hospital, Gentofte, Copenhagen
20 participants
Est. completion 2021-07
Other conditions: Diabetes After Total Pancreatectomy
View official trial listing →
